Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

Change in number of votes

Biotage
Download udgivelse

As previously announced, Biotage AB (publ) (“Biotage”) has during July 2024 re-classified 41,087 class C shares to 41,087 ordinary shares in connection with the completion of the long-term incentive plan adopted on the Annual General Meeting 2021 (“LTIP 2021”). The re-classification was carried out by Biotage in order to (i) deliver ordinary shares to participants in LTIP 2021 and (ii) sell ordinary shares in the market in order to cover social contributions arising as a result of LTIP 2021.

Prior to the re-classification, the total number of outstanding shares in Biotage amounted to 80,667,695 and the total number of votes amounted to 80,074,136. Through the re-classification, the total number of votes in Biotage has increased by 36,978.3 while the total number of shares remain unchanged. As of today, the last trading day of the month, the total number of registered shares in Biotage amounts to 80,667,695, whereof 80,049,272 are ordinary shares and 618,423 are class C shares held by Biotage. As of today, the number of votes in Biotage amounts to 80,111,114.3, and the registered share capital amounts to SEK 112,128,096.05.

Contacts


Torben Jörgensen, Interim President & CEO
Tel: +46-707 49 05 84, torben.jorgensen@biotage.com

About Biotage


Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes.

Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Website: www.biotage.com

This information is information that Biotage is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2024-07-31 18:45 CEST.

Attachments


Change in number of votes

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team